{{Rsnum
|rsid=13113918
|Gene=SLC2A9
|Chromosome=4
|position=9996869
|Orientation=plus
|GMAF=0.1607
|Gene_s=SLC2A9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 38.9 | 57.5
| HCB | 0.0 | 3.7 | 96.3
| JPT | 0.0 | 3.6 | 96.4
| YRI | 4.1 | 36.7 | 59.2
| ASW | 5.4 | 39.3 | 55.4
| CHB | 0.0 | 3.7 | 96.3
| CHD | 0.0 | 9.2 | 90.8
| GIH | 0.0 | 38.6 | 61.4
| LWK | 6.5 | 28.7 | 64.8
| MEX | 5.2 | 31.0 | 63.8
| MKK | 3.2 | 37.8 | 59.0
| TSI | 3.0 | 34.7 | 62.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21186168
|Title=Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families
|OA=1
}}

{{PMID Auto
|PMID=23272134
|Title=Changes in uric acid levels following bariatric surgery are not associated with SLC2A9 variants in the Swedish Obese Subjects Study
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}